228 related articles for article (PubMed ID: 27521883)
1. Management Strategies for the Ovaries at the Time of Hysterectomy for Benign Disease.
Matthews CA
Obstet Gynecol Clin North Am; 2016 Sep; 43(3):539-49. PubMed ID: 27521883
[TBL] [Abstract][Full Text] [Related]
2. A critical evaluation of the evidence for ovarian conservation versus removal at the time of hysterectomy for benign disease.
Matthews CA
J Womens Health (Larchmt); 2013 Sep; 22(9):755-9. PubMed ID: 23865788
[TBL] [Abstract][Full Text] [Related]
3. Salpingo-oophorectomy at the Time of Benign Hysterectomy: A Systematic Review.
Evans EC; Matteson KA; Orejuela FJ; Alperin M; Balk EM; El-Nashar S; Gleason JL; Grimes C; Jeppson P; Mathews C; Wheeler TL; Murphy M;
Obstet Gynecol; 2016 Sep; 128(3):476-85. PubMed ID: 27500347
[TBL] [Abstract][Full Text] [Related]
4. Oophorectomy vs ovarian conservation with hysterectomy: cardiovascular disease, hip fracture, and cancer in the Women's Health Initiative Observational Study.
Jacoby VL; Grady D; Wactawski-Wende J; Manson JE; Allison MA; Kuppermann M; Sarto GE; Robbins J; Phillips L; Martin LW; O'Sullivan MJ; Jackson R; Rodabough RJ; Stefanick ML
Arch Intern Med; 2011 Apr; 171(8):760-8. PubMed ID: 21518944
[TBL] [Abstract][Full Text] [Related]
5. National trends of adnexal surgeries at the time of hysterectomy for benign indication, United States, 1998-2011.
Mikhail E; Salemi JL; Mogos MF; Hart S; Salihu HM; Imudia AN
Am J Obstet Gynecol; 2015 Nov; 213(5):713.e1-13. PubMed ID: 25935772
[TBL] [Abstract][Full Text] [Related]
6. ACOG Committee Opinion No. 774 Summary: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.
Obstet Gynecol; 2019 Apr; 133(4):842-843. PubMed ID: 30913193
[TBL] [Abstract][Full Text] [Related]
7. The impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer--a population-based data linkage study.
Obermair A; Youlden DR; Baade PD; Janda M
Int J Cancer; 2014 May; 134(9):2211-22. PubMed ID: 24127248
[TBL] [Abstract][Full Text] [Related]
8. Ovarian conservation versus bilateral oophorectomy at the time of hysterectomy for benign disease.
Parker WH
Menopause; 2014 Feb; 21(2):192-4. PubMed ID: 23880797
[TBL] [Abstract][Full Text] [Related]
9. [Profits of post-menopausal ovarian conservation at the time of hysterectomy for benign disease: mirage or reality?].
Ouldamer L; Marret H; Jacquet A; Denakpo J; Body G
J Gynecol Obstet Biol Reprod (Paris); 2013 Apr; 42(2):123-9. PubMed ID: 23201029
[TBL] [Abstract][Full Text] [Related]
10. Ovarian cancer incidence and death in average-risk women undergoing bilateral salpingo-oophorectomy at benign hysterectomy.
Cusimano MC; Ferguson SE; Moineddin R; Chiu M; Aktar S; Liu N; Baxter NN
Am J Obstet Gynecol; 2022 Feb; 226(2):220.e1-220.e26. PubMed ID: 34563499
[TBL] [Abstract][Full Text] [Related]
11. Elective oophorectomy for benign gynecological disorders.
Shoupe D; Parker WH; Broder MS; Liu Z; Farquhar C; Berek JS
Menopause; 2007; 14(3 Pt 2):580-5. PubMed ID: 17476148
[TBL] [Abstract][Full Text] [Related]
12. Interventions to reduce the risk of ovarian and fallopian tube cancer: A European Menopause and Andropause Society Postition Statement.
Pérez-López FR; Ceausu I; Depypere H; Kehoe S; Lambrinoudaki I; Mueck A; Senturk LM; Simoncini T; Stevenson JC; Stute P; Rees M
Maturitas; 2017 Jun; 100():86-91. PubMed ID: 28389043
[TBL] [Abstract][Full Text] [Related]
13. Attitudes of Israeli gynecologists towards risk reduction salpingo-oophorectomy at hysterectomy for benign conditions and the use of hormonal therapy.
Assaf W; Andraous M; Lavie O; Segev Y
Eur J Obstet Gynecol Reprod Biol; 2022 May; 272():48-54. PubMed ID: 35279641
[TBL] [Abstract][Full Text] [Related]
14. Should the ovaries be removed or retained at the time of hysterectomy for benign disease?
Hickey M; Ambekar M; Hammond I
Hum Reprod Update; 2010; 16(2):131-41. PubMed ID: 19793841
[TBL] [Abstract][Full Text] [Related]
15. Ovarian conservation at the time of hysterectomy for benign disease.
Parker WH; Broder MS; Liu Z; Shoupe D; Farquhar C; Berek JS
Clin Obstet Gynecol; 2007 Jun; 50(2):354-61. PubMed ID: 17513923
[TBL] [Abstract][Full Text] [Related]
16. ACOG Committee Opinion No. 774: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.
Obstet Gynecol; 2019 Apr; 133(4):e279-e284. PubMed ID: 30913199
[TBL] [Abstract][Full Text] [Related]
17. To oophorectomy or not to oophorectomy: Practice patterns among urologists treating bladder cancer.
Sussman RD; Han CJ; Marchalik D; Carvahlo FL; Davis MF; Richter LA; Wethington SL; Stamatakis L
Urol Oncol; 2018 Mar; 36(3):90.e1-90.e7. PubMed ID: 29273351
[TBL] [Abstract][Full Text] [Related]
18. Ovarian conservation at the time of hysterectomy for benign disease.
Parker WH; Broder MS; Liu Z; Shoupe D; Farquhar C; Berek JS
Obstet Gynecol; 2005 Aug; 106(2):219-26. PubMed ID: 16055568
[TBL] [Abstract][Full Text] [Related]
19. Ovarian cancer risk after salpingectomy: a nationwide population-based study.
Falconer H; Yin L; Grönberg H; Altman D
J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25628372
[TBL] [Abstract][Full Text] [Related]
20. Ovarian conservation vs removal at the time of benign hysterectomy.
Adelman MR; Sharp HT
Am J Obstet Gynecol; 2018 Mar; 218(3):269-279. PubMed ID: 28784419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
